HomeDRUG • NASDAQ
add
Bright Minds Biosciences Inc
Previous close
$86.50
Day range
$85.50 - $91.00
Year range
$23.18 - $123.75
Market cap
1.21B CAD
Avg Volume
119.55K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.74M | 325.10% |
Net income | -7.57M | -15,349.58% |
Net profit margin | — | — |
Earnings per share | -0.97 | -9,800.00% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 89.05M | 53.80% |
Total assets | 90.88M | 55.62% |
Total liabilities | 1.60M | 179.80% |
Total equity | 89.28M | — |
Shares outstanding | 9.79M | — |
Price to book | 7.54 | — |
Return on assets | -19.23% | — |
Return on capital | -19.65% | — |
Cash Flow
Net change in cash
| (CAD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -7.57M | -15,349.58% |
Cash from operations | -5.82M | -289.18% |
Cash from investing | — | — |
Cash from financing | 13.39M | -74.27% |
Net change in cash | 6.14M | -88.23% |
Free cash flow | -4.01M | -339.54% |
About
Founded
2017
Website
Employees
26
